Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CDT Equity Inc.
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
June 1, 2026
CDT Announces Canadian Patent for AZD5904 in Male Infertility
May 31, 2026
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
May 28, 2026
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
May 28, 2026
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
May 25, 2026
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
May 24, 2026
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
May 22, 2026
CDT Equity Inc. Announces Reverse Stock Split
May 22, 2026
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
May 22, 2026
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
May 20, 2026
1
2
Next Page
→